news tirzepatide Peptide of the Week: Tirzepatide, a Game Changer for Type 2 Diabetes and Obesity Management Weight-loss jab Mounjaro trial begins

Maritim AC, Sanders A, Watkins Iii JB

ClinicalTrials.gov lists active retatrutide studies that are recruiting participants

This news is very encouraging for people with overweight or obesity because no treatment specifically directed at the management of obesity and overweight in people without Type 1 or Type 2 diabetes has been tested in a randomised trial and been shown to influence cardiovascular outcomes, said lead study author A

Survodutide has also received FDA fast-track designation for adults with MASH (NCT04771273)

This flat-rate model lets you focus purely on clinical optimization: finding the injection time that fits your lifestyle, managing side effects with smart meal choices, and allowing your dose to increase gradually as your body adapts